Assessment of Opioid Analgesia in Sickle Cell

NCT00513864 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Sickle Cell Disease

Interventions

DRUG: Dextromethorphan
DRUG: Codeine
DRUG: Morphine

Sponsor

Children's National Research Institute